About this trial
This randomized controlled trial (RCT) compares the 24-month clinical performance of endocrown restorations fabricated by two digital manufacturing pathways: additive manufacturing using 3D-printed ceramic-filled photopolymer resin (VarseoSmile TriniQ, BEGO) versus subtractive computer-aided design/computer-aided manufacturing (CAD/CAM) milling from hybrid nano-ceramic blocks (HC Hard Block, Shofu). Sixty endocrowns will be placed in endodontically treated posterior molars and evaluated using modified United States Public Health Service (USPHS) criteria at 6, 12, and 24 months. The trial is conducted at the Conservative Dentistry Department, Faculty of Dentistry, Cairo University.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 25-45 years, male or female
Endodontically treated molar tooth with radiographically confirmed treatment success and no clinical signs of failure
Sufficient remaining coronal structure for endocrown preparation: minimum three walls, wall thickness 1.5 mm or greater, pulp chamber depth 3 mm or greater, supragingival preparation margins
Completely erupted tooth with intact periodontal support
Disqualifiers
Diagnosed parafunctional habit or nocturnal bruxism
Uncontrolled systemic illness or physical disability precluding safe participation
Heavy tobacco use
Current or suspected pregnancy
Trial design
Parallel
Treatments tested in this trial
CAD/CAM Milled HC Hard Block Endocrown
DeviceEndocrown restoration milled from HC Hard Block hybrid nano-ceramic (Shofu Inc., Japan) using a five-axis wet-milling CAD/CAM unit. Restoration designed with ExoCAD software, finished and glazed per manufacturer protocol, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).
3D-Printed VarseoSmile TriniQ Endocrown
DeviceEndocrown restoration 3D-printed using VarseoSmile TriniQ ceramic-filled photopolymer resin (BEGO GmbH \& Co. KG, Germany) on a 4K LCD printer at 30-45 degree build angle. Post-cured under nitrogen atmosphere, surface glazed, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).
Treatment groups
Trial outcomes
Primary outcomes
Restoration Fracture Resistance
Assessed using modified USPHS criteria: Alpha = absence of fracture; Bravo = minor chip amenable to repair; Charlie = catastrophic fracture, unrestorable
Secondary outcomes
Retention
Modified USPHS: Alpha = in situ; Bravo = partial displacement; Charlie = complete loss
Marginal Discoloration
Modified USPHS: Alpha = absent; Bravo = superficial; Charlie = penetrating
Surface Texture
Modified USPHS: Alpha = smooth; Bravo = minor irregularities; Charlie = extensive breakdown
Anatomic Form
Modified USPHS: Alpha = conforms to natural contour; Bravo = discrepancy present, dentin intact; Charlie = dentin or base exposed
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: